As the cost of gene sequencing continues to decrease, we have an unprecedented amount of data about our genome that’s helping us understand more about our bodies. This area presents a lot of opportunities for pharmaceutical companies, health insurance, and investors as both tech and biology converge.
But how much of this is hype and how is genomics actually being used today?
In this webinar we’ll talk about:
Key developments enabling genomics today
Frameworks for understanding different the value add and business models of different genomics startups
Case studies of specific genomics companies
Who the active players in the space are and important moves that corporations like Illumina and Roche have made
Opportunities in the services and application layer as more genetic data is created